Companies: 10,795·Total market cap: $144.5T
Diebold Nixdorf, Incorporated

Diebold Nixdorf, Incorporated

DBDNYSETechnology● Active
$82.83
+$1.69(+2.08%)
Market Cap$2.9B
P/E Ratio
52W High$89.05
52W Low$49.15

Diebold Nixdorf, Incorporated (DBD) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

dbd · stock forecast · 13 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 13 Wall Street analysts in the past 3 months

SellBuy

Buy

13 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
5
Hold
5
Sell
3
Strong Sell
0
Total: 13 · Buy rate: 38.5%

12-Month Price Target

High

$100

Consensus

$100

+20.6% upside

Low

$100

Median: $100 · Last Close: $82.94

The Diebold Nixdorf, Incorporated (DBD) analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month DBD price target is $100.00, representing +20.6% upside from the current price of $82.94.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Analyst price target coverage is insufficient to generate a forecast chart for this stock.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$86.614.42%

1-day model range: $86.18–$87.03. Peak: $87.03 (+4.42%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$149+80.0%
2028$221+166.4%
2029$285+243.1%
2030$334+302.4%
2031+344.1%
Confidence:MediumCapped at 80% annual limit

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%0%7%
13Buy
0Neutral
1Sell
RSI (14)80.5Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · DBD · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$81.99BUY
MA 10$81.25BUY
MA 20$76.74BUY
MA 50$79.38BUY
MA 100$76.96BUY
MA 200$69.51BUY
Current $DBD · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$81.87BUY
EMA 10$80.57BUY
EMA 20$79.16BUY
EMA 50$78.27BUY
EMA 100$75.93BUY
EMA 200$70.30BUY
Current $DBD · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
DA Davidson2026-05-04
Maintains
BuyBuy
DA Davidson2026-04-21
Maintains
BuyBuy
Wedbush2026-02-13
Maintains
OutperformOutperform
DA Davidson2026-02-13
Maintains
BuyBuy
Wedbush2026-02-09
Maintains
OutperformOutperform
Wedbush2025-11-18
Maintains
OutperformOutperform
Wedbush2025-11-06
Maintains
OutperformOutperform
Wedbush2025-10-28
Maintains
OutperformOutperform
DA Davidson2025-08-19
Maintains
BuyBuy
Wedbush2025-08-07
Maintains
OutperformOutperform

Wall Street analysts have recently issued updated ratings on Diebold Nixdorf, Incorporated (DBD) stock. Of the recent 86 rating actions, 16 were upgrades and 14 were downgrades. 13 analysts currently cover DBD.

Analyst Recommendation Trends

Buy ratings211
Hold ratings00
Sell ratings00

DBD analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$3.8B

↓ 0.0% YoY

Revenue Next Year

$3.8B

↓ 1.7% YoY

EPS This Year

$51.21

EPS Next Year

$3.72

↓ 92.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast DBD EPS of $51.21 for the current fiscal year, based on estimates from 1 analysts. The DBD revenue forecast is $3.8B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The DBD stock forecast is supported by two independent data sources: analyst consensus ratings from 13 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus DBD price target is $100.00 (+20.6% upside), with an analyst consensus of Buy.

The DBD short-term stock prediction for tomorrow is $86.61 (+4.42%). The DBD stock price prediction for 2027 estimates an average of $149. The DBD stock prediction for 2030 projects a range of $316–$352.

Diebold Nixdorf, Incorporated trades on NYSE under the ticker DBD. The DBD stock outlook for 2027 is broadly positive, supported by a Buy consensus among 38% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

DBD forecast · 8 questions

According to 13 Wall Street analysts, the average 12-month DBD price target is $100.00, with a high forecast of $100.00 and a low of $100.00. The median price target is shown in the chart above when available. This implies +20.6% potential upside from the current price of $82.94.

DBD price targetWhat is DBD price targetDBD analyst price targetDBD 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.